All In MedTech

Device Trial Radar · NCT03057301

Assessment of Home Tonometry in Glaucoma

Last checked: Nov 19, 2026Latest source record: Nov 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

100

Planned (sponsor's estimate)

Start

Apr 1, 2016

Primary completion

May 17, 2017

Study completion May 17, 2017

Sponsor

Lead sponsor
NHS LothianGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
Feb 20, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 16 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Worldwide, glaucoma is the most common cause of irreversible blindness. The major risk factor is raised pressure within the eye (intraocular pressure, IOP). IOP is typically measured using Goldman applanation tonometry (GAT). This involves instilling anaesthetic eye drops and using a probe to contact the cornea and obtain a pressure measurement. A major disadvantage of GAT is that only limited numbers of pressure measurements can be obtained, whereas IOP is known to vary throughout the day and in ¾ of people is highest during the night. The result is that clinicians have poor understanding of patient's 24 hour IOPs and the effect that this might have on their glaucoma. This is a serious limitation as the treatment of glaucoma depends on lowering IOP. Recently a new device has become available, designed specifically for home IOP monitoring. The iCare HOME tonometer is a CE marked commercial device (http://www.icaretonometer.com/products/icare-home-tonometer/) that can be used to gain insight into 24-hour IOP fluctuations. The investigators wish to determine the feasibility of home IOP monitoring using this device. The iCare HOME tonometer depends on the patient performing self-tonometry. Testing one's own IOP may be technically difficult and it is likely that large numbers of patients will struggle with this.

Conditions

  • Glaucoma
  • Intraocular Pressure

Interventions

  • iCare home tonometerDevice

    All subjects will be taught to use the home care tonometer.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Whether or not the subject is deemed successful in using the home tonometerTime frame: On baseline visit

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Princess Alexandra Eye Pavilion

    Edinburgh, Midlothian, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.